Sequencing Webinars

Genome editing

Genome editing workflow facilitated by the Thermo Fisher Scientific portfolio solution
Dr. Steve Jackson, Product applications, Thermo Fisher Scientific
 Watch ›

Cell line authentication
A complete workflow for human cell line authentication
Dr. Steve Jackson, Product applications, Thermo Fisher Scientific
 Watch ›

Oncology research

Advancing precision immunotherapy through next-generation sequencing of T cell receptors, Parts I and II
Dr. Timothy Looney, Staff Scientist, Bioinformatics, at Thermo Fisher Scientific
Watch ›

Advances in NGS for Ultra-High Sensitivity Applications in Translational and Clinical Research
Dr. Hans Atli Dahl, Co-founder & Chief Technology Officer, Amplexa Genetics
Watch ›

Rare allele detection in FFPE and cfDNA pathology research samples
Dr. Karl Kashofer, Head of the Laboratory for Diagnostic Genome Analysis, Department of Pathology, Medical University of Graz
Watch ›

From qualitative to quantitative: experiences with a cfDNA assay in metastatic breast cancer Liya Xu, PhD
Postdoctoral Scholar, Kuhn/Hicks Laboratory, USC Michelson Center for Convergent Bioscience
Watch › 

Latest advances in tumor genomic profiling for challenging samples
Dr. Navid Sadri, Clinical Assistant Professor, Pathology, University Hospitals Cleveland Medical Center
Dr. Jody McIntyre, Associate Director, Oncology Product Management, Thermo Fisher Scientific
Watch ›

Investigating the Genetics of Human Macrophage Response and Resistance to Mycobacterium tuberculosis with AmpliSeq Gene Expression Panels
Audrey Papp, B.S., MT ASCP(H), CLSp MB, Technical Director, The Ohio State University
 Watch ›

The journey to realizing the promise of precision medicine
Timothy Triche, MD, PhD; Co-Director, Center for Personalized Medicine Program; Professor of Pathology and Pediatrics, USC Keck School of Medicine; Children's Hospital Los Angeles Center for Personalized Medicine
P. Mickey Williams, PhD, Director, Molecular Characterization Laboratory, National Cancer Institute at Frederick
 Watch ›  

Discover potentially predictive immuno-oncology biomarkers using next-gen sequencing
Fiona Hyland, Director of Bioinformatics R&D, Thermo Fisher Scientific
Carl Morrison MD, DVM, Professor of Pathology at Roswell Park Cancer Institute; President of OmniSeq Precision Medicine Technology
 Watch ›

Variant detection in cell-free DNA from NSCLC using NGS
Tracy Stockley PhD, FCCMG, FACMG, Associate Professor, Princess Margaret Cancer Centre
 Watch ›

Extended RAS Research Panel on Applied Biosystem’s new SeqStudio Genetic Analyzer
Dr. Luca Quagliata, Sr. Director, University Hospital Basel
 Watch ›

Reproductive genomics research
Rapid PGS workflow using next-generation sequencing
Fabien Murisier, Scientific director, Centre for Medically Assisted Procreation (CPMA)
Luis A. Alcaraz, Director, Bioarray
 Watch ›

Gene expression research
Exosome miRNA sequencing for biomarker profiling using Ion S5 System and Ion Total RNA-Seq Kit
Lesley Cheng, PhD, La Trobe University
 Watch ›

Inherited disease research
Application of targeted next-generation sequencing (NGS) panels in neurodevelopmental disorder research
Alessandra Murgia, Associated Professor, Department of Woman and Child Health, University of Padova, Italy
Francisco Hernandez-Guzman, Senior Product Manager, Clinical Sequencing Division, Thermo Fisher Scientific
 Watch ›
 
Enabling neurological disease research via DNA fragment analysis

Dr. Gary Latham, Sr. Vice President, Research and Development, Asuragen
 Watch ›